Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?
Identifieur interne : 000B05 ( Main/Corpus ); précédent : 000B04; suivant : 000B06Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?
Auteurs : E. ChabrièreSource :
- New microbes and new infections [ 2052-2975 ] ; 2021.
Abstract
During COVID-19 pandemic the Gilead Sciences stock prices rose sharply with large variations. These fluctuations have been tentatively related to communications, publications or leaks about remdesivir or hydroxychloroquine/azithromycin treatment.
DOI: 10.1016/j.nmni.2020.100711
PubMed: 33014379
PubMed Central: PMC7525330
Links to Exploration step
pubmed:33014379Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?</title>
<author><name sortKey="Chabriere, E" sort="Chabriere, E" uniqKey="Chabriere E" first="E" last="Chabrière">E. Chabrière</name>
<affiliation><nlm:affiliation>Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33014379</idno>
<idno type="pmid">33014379</idno>
<idno type="doi">10.1016/j.nmni.2020.100711</idno>
<idno type="pmc">PMC7525330</idno>
<idno type="wicri:Area/Main/Corpus">000B05</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B05</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?</title>
<author><name sortKey="Chabriere, E" sort="Chabriere, E" uniqKey="Chabriere E" first="E" last="Chabrière">E. Chabrière</name>
<affiliation><nlm:affiliation>Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">New microbes and new infections</title>
<idno type="ISSN">2052-2975</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">During COVID-19 pandemic the Gilead Sciences stock prices rose sharply with large variations. These fluctuations have been tentatively related to communications, publications or leaks about remdesivir or hydroxychloroquine/azithromycin treatment.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33014379</PMID>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2052-2975</ISSN>
<JournalIssue CitedMedium="Print"><Volume>39</Volume>
<PubDate><Year>2021</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>New microbes and new infections</Title>
<ISOAbbreviation>New Microbes New Infect</ISOAbbreviation>
</Journal>
<ArticleTitle>Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?</ArticleTitle>
<Pagination><MedlinePgn>100711</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nmni.2020.100711</ELocationID>
<Abstract><AbstractText>During COVID-19 pandemic the Gilead Sciences stock prices rose sharply with large variations. These fluctuations have been tentatively related to communications, publications or leaks about remdesivir or hydroxychloroquine/azithromycin treatment.</AbstractText>
<CopyrightInformation>© 2020 Published by Elsevier Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chabrière</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>09</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>New Microbes New Infect</MedlineTA>
<NlmUniqueID>101624750</NlmUniqueID>
<ISSNLinking>2052-2975</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Azithromycin</Keyword>
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">remdesivir</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>06</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>06</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>10</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>18</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33014379</ArticleId>
<ArticleId IdType="doi">10.1016/j.nmni.2020.100711</ArticleId>
<ArticleId IdType="pii">S2052-2975(20)30063-9</ArticleId>
<ArticleId IdType="pmc">PMC7525330</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
<ReferenceList><Reference><Citation>Lancet. 2020 Apr 11;395(10231):1225-1228</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32178769</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mediators Inflamm. 2012;2012:649570</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22719178</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32054787</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2019 Dec 12;381(24):2293-2303</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31774950</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32275812</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105924</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32081636</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Travel Med Infect Dis. 2020 Mar - Apr;34:101663</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32289548</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 16;395(10236):1569-1578</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32423584</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pharmacol. 2009 Dec 25;625(1-3):220-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19836374</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Mar 5;382(10):929-936</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32004427</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B05 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000B05 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:33014379 |texte= Does IHU-Méditerranée Infection influence Gilead Sciences' stock price? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33014379" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |